Cancer Vaccine Cuts the Risk of Melanoma Recurrence, Merck and Moderna Report

Merck and Moderna released detailed results on an experimental vaccine to treat the skin cancer.
Read the full story at The New York Times ↗
ImpactTop story 61/100
Why it mattersRule-based estimate: covered by 5 sources; trust 9/10.
RegionsUnited States
Published11 h ago (Thu, 22 Oct 2026 22:48:01 GMT)
RetrievedFri, 23 Oct 2026 01:00:25 GMT via rss
ClassifiedFri, 23 Oct 2026 08:01:46 GMT by nimble
AuthorNina Agrawal